Advertisement

Infection

, Volume 26, Issue 6, pp 399–401 | Cite as

Necrotizing fasciitis caused byVibrio vulnificus: First published infection acquired in Turkey is the second time a strain is isolated in Germany

  • R. Horré
  • S. Becker
  • G. Marklein
  • T. Shimada
  • R. Stephan
  • K. Steuer
  • E. Bierhoff
  • K. P. Schaal
Brief Report

Summary

Vibrio vulnificus, a marine vibrio, has recently been recognized as a potential human pathogen. It causes human infections with mortality rates up to 60%. Until 1991, most human isolations were reported from the USA, Japan and Taiwan. The second strain isolated in Germany is documented and a significant case ofV. vulnificus infection acquired in Turkey is published for the first time.

Keywords

Vibrio Necrotizing Fasciitis Chronic Venous Insufficiency Dutch Coast Rofloxacin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hoge, C. W., Watsky, D., Peeler, R. N., Libonati, J. P., Israel, E., Morris, J. G.: Epidemiology and spectrum ofVibrio infections in a Chesapeake Bay Community. J. Infect. Dis. 160 (1989) 985–993.PubMedGoogle Scholar
  2. 2.
    Veenstra, J., Rietra, P. J. G. M., Coster, J. M., Slaats, E., Dirks-Go, S.: Seasonal variations in the occurrence ofVibrio vulnificus along the Dutch coast. Epidemiol. Infect. 112 (1994) 285–290.CrossRefPubMedGoogle Scholar
  3. 3.
    Amaro, C., Biosca, E. G., Fouz, B., Alcaide, E., Esteve, C.: Evidence that water transmitsVibrio vulnificus biotype 2. Appl. Environ. Microbiol. 61 (1995) 1133–1137.PubMedGoogle Scholar
  4. 4.
    Nilsson, L., Oliver, J. D., Kjelleberg, S.: Resuscitation ofVibrio vulnificus from the viable but nonculturable state. J. Bacteriol. 173 (1991) 5054–5059.PubMedGoogle Scholar
  5. 5.
    Bock, T., Christensen, N., Eriksen, N. H. R., Winter, S., Rygaard, H., Jorgensen, F.: The first fetal case ofVibrio vulnificus infection in Denmark. APMIS 102 (1994) 874–876.CrossRefPubMedGoogle Scholar
  6. 6.
    Hoyer, J., Engelmann, E., Liehr, R.-M., Hahn, H., Shimada, T.: Septic shock due toVibrio vulnificus serogroup 04 wound infection acquired from the Baltic Sea. Eur. J. Clin. Microbiol 14 (1995) 1016–1018.CrossRefGoogle Scholar
  7. 7.
    Nishina, Y., Miyoshi, S.-I., Nagase, A., Shinoda, S.: Significant role of an exocellular protease in utilization of beme byVibrio vulnificus. Infect. Immun. 60 (1992) 2128–2132.PubMedGoogle Scholar
  8. 8.
    Melhus, A., Holmdahl, T., Tjernberg, I.: First documented case of bacteremia withVibrio vulnificus in Sweden. Scand. J. Infect. Dis. 27 (1995) 81–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Brook, I., Frazier, E. H.: Clinical and microbiological, features of necrotizing fasciitis. J. Clin. Microbiol. 33 (1995) 2382–2387.PubMedGoogle Scholar
  10. 10.
    Baethge, B. A., West, B. C.:Vibrio vulnificus: did Hippocrates describe a fatal case? Rev. Infect. Dis. 10 (1988) 614–615.PubMedGoogle Scholar
  11. 11.
    Dalsgaard, A., Dalsgaard, I., Hoi, L., Larsen, J. L.: Comparison of a commercial biochemical kit and an oligonucleotide probe for identification of environmental isolates ofVibrio vulnificus. Lett. Appl. Microbiol. 22 (1996) 184–188.CrossRefGoogle Scholar
  12. 12.
    Meadors, M. C., Pankey, G. A.:Vibrio vulnificus wound infection treated successfully with oral ciprofloxacin. J. Infect. 20 (1990) 88–89.CrossRefPubMedGoogle Scholar

Copyright information

© MMV Medien & Medizin Verlagsgesellschaft mbH, München 1998

Authors and Affiliations

  • R. Horré
    • 1
  • S. Becker
    • 1
  • G. Marklein
    • 1
  • T. Shimada
    • 5
  • R. Stephan
    • 4
  • K. Steuer
    • 2
  • E. Bierhoff
    • 3
  • K. P. Schaal
    • 1
  1. 1.Institut für Medizinische Mikrobiologie und ImmunologieUniverstät BonnBonn
  2. 2.Institut für UnfallchirurgieUniversität BonnBonn
  3. 3.Institut für PathologieUniversität BonnBonn
  4. 4.Robert-Koch-InstitutBerlinGermany
  5. 5.Dept. of BacteriologyNational Inst. of HealthKamiosakiJapan

Personalised recommendations